Although increased RNF5 expression might be commonly associated with tumor progression and decreased survival [18, 25–27], the opposite findings have been reported in malignant breast cancers [21, 28]; however, the latter are related to a p53-mutated background. This evidence concerns the gene RNF5 and neoplasm.